We develop next-generation health technologies that combine advanced formulation science, precision nutraceuticals, regulatory expertise and scalable innovation to improve human health.
The future of health is not built on generic products. It requires deeper scientific insight, more intelligent delivery systems, stronger evidence, thoughtful regulation and a clear understanding of changing consumer and patient needs. Health innovation at the frontier demands not just scientific rigor, but the strategic clarity to translate that rigor into solutions that are commercially compelling and clinically credible.
BeWiSe Pharma develops premium health innovation platforms designed to make bioactive compounds more effective, more relevant and more commercially viable. We combine scientific depth with practical execution—from early concept and formulation design to regulatory strategy, validation, scale-up and market readiness—delivering innovation that performs at every stage of the product lifecycle.
Our integrated development model ensures that scientific ambition and commercial strategy advance in parallel—reducing time to market, managing regulatory risk, and creating products built to win.
We identify unmet needs, define high-potential product opportunities and build concepts with a clear scientific, regulatory and commercial rationale—so every project begins with a defensible thesis and a viable path to market.
We develop evidence-led formulations, select high-value active ingredients, optimise dosage regimens and determine the most appropriate delivery format for each target consumer, health claim and market context.
Regulatory thinking is integrated into our development process from the outset. We support ingredient assessment, claims strategy, labelling review and market-entry planning for Türkiye, Europe and international markets—helping partners navigate complexity with confidence.
Through qualified production partners, we support technical transfer, pilot batches, quality requirements, packaging strategy and commercial manufacturing planning—bridging the critical gap between laboratory innovation and shelf-ready product.
BeWiSe Pharma's innovation portfolio spans four deeply interconnected domains—each addressing a critical gap where science, market demand, and regulatory sophistication converge to create transformational opportunity.
We develop high-value nutraceutical and health-product concepts informed by pharmacology, bioavailability, ingredient synergy, dosage optimisation and consumer experience. Our work includes advanced delivery approaches designed to improve the stability, usability and performance potential of bioactive compounds—creating differentiated products that perform where conventional formulations fall short.
We are building data-informed nutraceutical models that evolve with biomarker insights, lifestyle data and individual health priorities. Our goal is to move decisively beyond one-size-fits-all supplementation toward targeted, evidence-led wellness protocols that are both scientifically meaningful and commercially scalable.
Women's health is a core area of expertise and strategic opportunity for BeWiSe Pharma. We develop evidence-led solutions for hormonal transitions, menopause, metabolic changes, cognitive wellbeing, sleep quality, vitality and healthy ageing—an underserved category where science-driven innovation has the power to create real and lasting impact.
We create premium concepts supporting metabolic resilience, energy metabolism, inflammation management, mobility, cognitive performance and long-term wellbeing. As longevity science matures into a commercial frontier, BeWiSe Pharma positions its partners at the leading edge of this high-growth category.
BeWiSe Pharma is founded and led by women with deep expertise across pharmacology, food engineering, regulatory affairs and health innovation. We bring a multidisciplinary perspective to health challenges that have historically been underexplored, underserved or approached without sufficient scientific nuance—giving our partners access to a differentiated lens that drives more meaningful product decisions.
Our work is shaped by pharmacological expertise, peer-reviewed research and a rigorous approach to formulation development. Every concept we advance is grounded in evidence, informed by the latest literature and tested against the highest standards of scientific integrity—so partners can speak with authority in both clinical and commercial contexts.
With extensive experience in dietary supplement regulation, food safety and product compliance across Türkiye, Europe and international markets, we help partners reduce regulatory risk and build market-ready solutions that are designed to last—not just to launch.
Our innovation model combines advanced formulation science, novel delivery platforms and data-informed personalisation—creating opportunities for differentiated intellectual property, strategic partnerships and scalable growth in one of the world's most dynamic sectors.
BeWiSe Pharma is designed from the ground up for deep, strategic collaboration. We work with organisations that share a commitment to rigorous science, commercial ambition and the conviction that health innovation can and should do more. Whether you are building a new product category, entering a new market or seeking a science partner with genuine regulatory depth, we are structured to accelerate your vision.
Deep-tech, health innovation, longevity and consumer health investors seeking high-potential, science-led opportunities.
Brands seeking differentiated, evidence-led product development that commands credibility at shelf and in clinical settings.
Organisations entering new health categories with the need for rigorous formulation, compliance and go-to-market support.
Evidence-led nutraceutical protocols designed to complement clinical practice and digital health ecosystems.
Technology partners and innovation ecosystems seeking translation of scientific findings into viable commercial health products.
Partners with qualified production capability and international market reach ready to scale science-first health concepts.
BeWiSe Pharma is built on the combined strength of two exceptional founders whose complementary expertise spans pharmacology, food engineering, regulatory science, management and entrepreneurial leadership. Together, they represent a rare convergence of deep scientific authority and strategic commercial acumen.
Dr. Selen Oflazer is a food engineer with an MBA and Ph.D. in Management and Organization. She brings more than a decade of experience in dietary supplement regulation, food safety and product compliance, including expertise developed within the Turkish Ministry of Agriculture and Forestry. At BeWiSe Pharma, she leads corporate strategy, regulatory intelligence, commercial development and strategic partnerships—connecting the precision of scientific innovation with the pragmatism of market opportunity and building an organisation designed to scale.
Prof. Dr. M. Betül Yerer Aycan is a pharmacist and Full Professor of Pharmacology with more than 25 years of experience in drug development, pharmacological research and evidence-based formulation science. She leads BeWiSe Pharma's scientific strategy, formulation development and validation approach. Her scientific leadership is reflected in more than 250 peer-reviewed publications—a body of work that provides BeWiSe Pharma with an extraordinary foundation of pharmacological credibility and intellectual depth.
BeWiSe Pharma is creating a new model for health-product innovation: women-led, science-driven, regulation-aware and designed for scalable, lasting impact. We are actively building partnerships with organisations that understand that the next wave of health value creation will belong to those who invest in superior science, smarter delivery and more intelligent regulation—starting now.
Your vision. Our science. The future of health.
Whether you are an investor identifying the next deep-tech health opportunity, a brand ready to move beyond commoditised formulation, or a research institution seeking a commercialisation partner with genuine scientific depth—we are ready to build something meaningful together.
We welcome enquiries from strategic investors, healthcare brands, research institutions, clinical partners and manufacturing organisations aligned with our mission to advance science-led health innovation.
BeWiSe Pharma